• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺肿瘤患者术后静脉血栓形成中D-二聚体的危险因素及临床意义

Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor.

作者信息

Wang Pan, Zhao Honglin, Zhao Qingchun, Ren Fan, Shi Ruifeng, Liu Xingyu, Liu Jinghao, Liu Hongyu, Chen Gang, Chen Jun

机构信息

Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Jun 30;12:5169-5179. doi: 10.2147/CMAR.S256484. eCollection 2020.

DOI:10.2147/CMAR.S256484
PMID:32636679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335272/
Abstract

BACKGROUND

The incidence of venous thromboembolism (VTE) is higher in patients with lung cancer. The aim of this study was to investigate the risk factors associated with postoperative VTE and explore the VTE predication capacity of D-dimer kinetics.

PATIENTS AND METHODS

Six hundred patients who had lung tumor surgery were analyzed retrospectively between January 2018 and August 2019, and venous ultrasound imaging and D-dimer examination before and after surgery were recommended to all operative patients. Of these 600 patients, 523 patients had venous thromboembolism after surgery, and 77 patients had not found. The general clinical data, postoperative prophylactic anticoagulant therapy, early systemic thromboprophylaxis, 50% increment of D-dimer, 100% increment of D-dimer, and perioperative (preoperative and days 1, 3, and 5 after surgery) D-dimer levels were collected. Logistic regression analysis was used to analyze the independent risk factors of postoperative VTE.

RESULTS

VTE developed in 77 (12.8%) patients. In a univariate analysis, age, surgical approach, tumor size, histology, postoperative preventive anticoagulation, postoperative limb compression therapy, postoperative hemostasis, duration of operation, early systemic thromboprophylaxis, 100% increment of D-dimer, preoperative and postoperative D-dimer level, intraoperative blood loss, and time spent in the hospital were significantly different between the thrombus group and nonthrombus group ( < 0.05). Multivariate analysis showed that age >60 years ( = 0.006) and D-dimer level on 5 days after surgery ( = 0.000) were significant independent risk factors for VTE. Postoperative D-dimer was significantly higher than the preoperative level ( < 0.001). Postoperative D-dimer level was significantly different between benign and malignant tumor groups ( < 0.05) and between the thrombus group and nonthrombus group ( < 0.001). Preventive anticoagulation and limb compression therapy starting from the first day after surgery was statistically significant between the thrombus group and the nonthrombus group ( < 0.05).

CONCLUSION

Continuous detection of D-dimer level after pulmonary tumor surgery combined with thrombotic-related risk factors can better evaluate the occurrence of VTE. Preventive anticoagulant therapy and limb compression therapy starting from the first day after surgery can effectively reduce the incidence of VTE.

摘要

背景

肺癌患者静脉血栓栓塞症(VTE)的发生率较高。本研究旨在探讨与术后VTE相关的危险因素,并探索D-二聚体动力学对VTE的预测能力。

患者与方法

回顾性分析2018年1月至2019年8月期间600例行肺肿瘤手术的患者,并建议所有手术患者术前行静脉超声成像及D-二聚体检查。在这600例患者中,523例术后发生静脉血栓栓塞,77例未发现。收集患者的一般临床资料、术后预防性抗凝治疗、早期全身血栓预防、D-二聚体升高50%、D-二聚体升高100%以及围手术期(术前及术后第1、3、5天)D-二聚体水平。采用Logistic回归分析术后VTE的独立危险因素。

结果

77例(12.8%)患者发生VTE。单因素分析显示,血栓组与非血栓组在年龄、手术方式、肿瘤大小、组织学类型、术后预防性抗凝、术后肢体压迫治疗、术后止血、手术时间、早期全身血栓预防、D-二聚体升高100%、术前及术后D-二聚体水平、术中出血量及住院时间等方面差异有统计学意义(<0.05)。多因素分析显示,年龄>60岁(=0.006)及术后第5天D-二聚体水平(=0.000)是VTE的显著独立危险因素。术后D-二聚体明显高于术前水平(<均数差0.001)。良性与恶性肿瘤组术后D-二聚体水平差异有统计学意义(<均数差0.05),血栓组与非血栓组术后D-二聚体水平差异有统计学意义(<均数差0.001)。术后第1天开始的预防性抗凝和肢体压迫治疗在血栓组与非血栓组之间差异有统计学意义(<均数差0.05)。

结论

肺肿瘤手术后持续检测D-二聚体水平并结合血栓形成相关危险因素,可更好地评估VTE的发生情况。术后第1天开始进行预防性抗凝治疗和肢体压迫治疗可有效降低VTE的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/a4460b19816d/CMAR-12-5169-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/de463dac2e15/CMAR-12-5169-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/c4da5d9c3f3b/CMAR-12-5169-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/2bb7d419a905/CMAR-12-5169-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/a4460b19816d/CMAR-12-5169-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/de463dac2e15/CMAR-12-5169-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/c4da5d9c3f3b/CMAR-12-5169-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/2bb7d419a905/CMAR-12-5169-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/7335272/a4460b19816d/CMAR-12-5169-g0004.jpg

相似文献

1
Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor.肺肿瘤患者术后静脉血栓形成中D-二聚体的危险因素及临床意义
Cancer Manag Res. 2020 Jun 30;12:5169-5179. doi: 10.2147/CMAR.S256484. eCollection 2020.
2
[Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].[肺癌手术后静脉血栓栓塞的相关危险因素:一项单中心研究]
Zhongguo Fei Ai Za Zhi. 2018 Oct 20;21(10):753-760. doi: 10.3779/j.issn.1009-3419.2018.10.04.
3
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.术后D-二聚体可预测接受泌尿外科肿瘤手术患者的静脉血栓栓塞。
Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26.
4
The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism.表皮生长因子受体(EGFR)重排的腺癌与静脉血栓栓塞的高发生率相关。
Ann Transl Med. 2019 Dec;7(23):724. doi: 10.21037/atm.2019.12.24.
5
Utility of plasma D-dimer for diagnosis of venous thromboembolism after hepatectomy.血浆D-二聚体在肝切除术后静脉血栓栓塞症诊断中的应用价值。
World J Clin Cases. 2024 Jan 16;12(2):276-284. doi: 10.12998/wjcc.v12.i2.276.
6
Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.中国卵巢癌围手术期患者静脉血栓栓塞症的危险因素及治疗
Medicine (Baltimore). 2018 Aug;97(31):e11754. doi: 10.1097/MD.0000000000011754.
7
[Analysis of incidence and risk factors for postoperative venous thromboembolism in patients with stageⅠ a non-small-cell lung cancer].[Ⅰa期非小细胞肺癌患者术后静脉血栓栓塞症的发生率及危险因素分析]
Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3417-3421. doi: 10.3760/cma.j.cn112137-20210418-00929.
8
Preoperative and postoperative clinical signatures of postgastrectomy venous thromboembolism in patients with gastric cancer: A retrospective cohort study.胃癌患者胃切除术后静脉血栓栓塞的术前和术后临床特征:一项回顾性队列研究。
Asian J Surg. 2023 Apr;46(4):1556-1563. doi: 10.1016/j.asjsur.2022.08.083. Epub 2022 Sep 9.
9
The significance of perioperative coagulation and fibrinolysis related parameters after lung surgery for predicting venous thromboembolism: a prospective, single center study.肺手术后围手术期凝血和纤溶相关参数对预测静脉血栓栓塞的意义:一项前瞻性单中心研究
J Thorac Dis. 2018 Apr;10(4):2223-2230. doi: 10.21037/jtd.2018.03.174.
10
Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.Caprini风险评估模型及肿瘤特异性D-二聚体水平升高在预测妇科恶性肿瘤手术患者术后静脉血栓栓塞中的应用价值
J Obstet Gynaecol Res. 2019 Mar;45(3):657-664. doi: 10.1111/jog.13832. Epub 2018 Nov 4.

引用本文的文献

1
Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study.基于机器学习的中国肺癌患者围手术期静脉血栓栓塞症的术前预测:一项回顾性队列研究
Front Oncol. 2025 Jun 25;15:1588817. doi: 10.3389/fonc.2025.1588817. eCollection 2025.
2
Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis.肺癌患者静脉血栓栓塞症的患病率及临床特征:一项系统评价和荟萃分析。
Front Oncol. 2024 Aug 14;14:1405147. doi: 10.3389/fonc.2024.1405147. eCollection 2024.
3
Incidence and risk factors of VTE in lung cancer: a meta-analysis.

本文引用的文献

1
Evaluation of a D-Dimer Protocol for Detection of Venous Thromboembolism.D-二聚体检测方案用于诊断静脉血栓栓塞症的评估。
World Neurosurg. 2020 Jan;133:e774-e783. doi: 10.1016/j.wneu.2019.09.160. Epub 2019 Oct 9.
2
Effectiveness of intraoperative administration of intermittent pneumatic compression in preventing deep vein thrombosis in lung cancer patients undergoing video-assisted thoracoscopic surgery lobectomy.术中给予间歇性气动压迫预防接受电视辅助胸腔镜肺叶切除术的肺癌患者深静脉血栓形成的有效性。
J Thorac Dis. 2019 Jul;11(7):2832-2838. doi: 10.21037/jtd.2019.07.07.
3
[Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
肺癌患者静脉血栓栓塞症的发生率及相关因素:一项荟萃分析。
Ann Med. 2024 Dec;56(1):2390200. doi: 10.1080/07853890.2024.2390200. Epub 2024 Aug 26.
4
Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.构建和验证预测 HGSOC 患者术后静脉血栓栓塞风险的列线图。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241255958. doi: 10.1177/10760296241255958.
5
[Analysis of the Incidence of Lower Limb Deep Venous Thrombosis 
and Its Related Risk Factors in the Postoperative Patients with Lung Cancer].[肺癌术后患者下肢深静脉血栓形成的发生率及其相关危险因素分析]
Zhongguo Fei Ai Za Zhi. 2023 May 20;26(5):386-391. doi: 10.3779/j.issn.1009-3419.2023.102.16.
6
Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review.肺癌患者静脉血栓栓塞症的管理:最新综述。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001493.
7
Risk Factor Analysis of Postoperative Venous Thromboembolism in Patients After Thoracoscopic Lobectomy.胸腔镜肺叶切除术后患者术后静脉血栓栓塞症的危险因素分析。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231156908. doi: 10.1177/10760296231156908.
8
Risk factors and potential predictors of pulmonary embolism in cancer patients undergoing thoracic and abdominopelvic surgery: a case control study.接受胸腹部和盆腔手术的癌症患者发生肺栓塞的危险因素及潜在预测因素:一项病例对照研究
Thromb J. 2022 Dec 22;20(1):80. doi: 10.1186/s12959-022-00442-7.
9
Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.基于列线图的肺癌住院患者静脉血栓栓塞症新型风险评估模型的推导、验证与评估:一项回顾性病例对照研究
Front Oncol. 2022 Oct 10;12:988287. doi: 10.3389/fonc.2022.988287. eCollection 2022.
10
The Efficacy of the Systemic Immune-Inflammation Index and Prognosis Nutritional Index for the Diagnosis of Venous Thromboembolism in Gastrointestinal Cancers.全身免疫炎症指数和预后营养指数在胃肠道癌静脉血栓栓塞诊断中的效能
J Inflamm Res. 2022 Aug 15;15:4649-4661. doi: 10.2147/JIR.S376601. eCollection 2022.
[肺癌手术后静脉血栓栓塞的相关危险因素:一项单中心研究]
Zhongguo Fei Ai Za Zhi. 2018 Oct 20;21(10):753-760. doi: 10.3779/j.issn.1009-3419.2018.10.04.
4
Prevalence of venous thromboembolism after lung surgery in China: a single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis†.中国肺手术后静脉血栓栓塞症的患病率:一项涉及未行围手术期静脉血栓栓塞症预防的肺切除术患者的单中心前瞻性队列研究†。
Eur J Cardiothorac Surg. 2019 Mar 1;55(3):455-460. doi: 10.1093/ejcts/ezy323.
5
The significance of perioperative coagulation and fibrinolysis related parameters after lung surgery for predicting venous thromboembolism: a prospective, single center study.肺手术后围手术期凝血和纤溶相关参数对预测静脉血栓栓塞的意义:一项前瞻性单中心研究
J Thorac Dis. 2018 Apr;10(4):2223-2230. doi: 10.21037/jtd.2018.03.174.
6
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.术后D-二聚体可预测接受泌尿外科肿瘤手术患者的静脉血栓栓塞。
Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26.
7
[Incidence of postoperative venous thromboembolism after thoracic surgery and its characteristic: a single center, prospective cohort study].[胸外科手术后静脉血栓栓塞症的发生率及其特征:一项单中心前瞻性队列研究]
Zhonghua Wai Ke Za Zhi. 2018 Apr 1;56(4):284-288. doi: 10.3760/cma.j.issn.0529-5815.2018.E008.
8
Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.肺癌患者抗凝治疗与血栓形成及死亡率预防的荟萃分析。
Thromb Res. 2017 Jun;154:28-34. doi: 10.1016/j.thromres.2017.03.024. Epub 2017 Apr 1.
9
Cancer and Venous Thromboembolic Disease: A Review.癌症与静脉血栓栓塞性疾病:综述
Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7.
10
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).2016年欧洲心脏病学会(ESC)实践指南委员会主持制定的关于癌症治疗与心血管毒性的立场文件:欧洲心脏病学会(ESC)癌症治疗与心血管毒性特别工作组。
Eur J Heart Fail. 2017 Jan;19(1):9-42. doi: 10.1002/ejhf.654. Epub 2016 Aug 27.